IMP-29, a novel IMP-type metallo-β-lactamase in Pseudomonas aeruginosa

Antimicrob Agents Chemother. 2012 Apr;56(4):2187-90. doi: 10.1128/AAC.05838-11. Epub 2012 Jan 30.

Abstract

Analysis of two clonally related multiresistant Pseudomonas aeruginosa isolates led to the identification of a novel IMP-type metallo-β-lactamase. IMP-29 was significantly different from the other IMP variants (the closest variant being IMP-5 with 93% amino acid identity). The bla(IMP-29) gene cassette was carried by a class 1 integron in strain 10.298, while in strain 10.266 it was located in a rearranged DNA region on a 30-kb conjugative plasmid. Biochemical analysis confirmed that IMP-29 efficiently hydrolyzed carbapenems.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Carbapenems / metabolism
  • DNA, Bacterial / genetics
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Fatal Outcome
  • Humans
  • Hydrolysis
  • Integrons / genetics
  • Male
  • Microbial Sensitivity Tests
  • Polymerase Chain Reaction
  • Pseudomonas Infections / drug therapy
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / enzymology*
  • Pseudomonas aeruginosa / genetics*
  • Shock, Septic / drug therapy
  • Shock, Septic / etiology
  • beta-Lactamases / genetics*

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • DNA, Bacterial
  • beta lactamase IMP-29, Pseudomonas aeruginosa
  • beta-Lactamases